Advanced Biomed Inc. (NASDAQ:ADVB) Short Interest Update

Advanced Biomed Inc. (NASDAQ:ADVB) saw a large decrease in short interest in the month of August. As of August 14th, there was short interest totaling 37,364 shares, a decrease of 34.7% from the July 30th total of 57,213 shares. Based on an average trading volume of 231,612 shares, the short-interest ratio is currently 0.2 days. Currently, 3.1% of the shares of the stock are short sold.

Advanced Biomed Stock Performance

Shares of ADVB opened at $10.44 on Wednesday. The firm has a market cap of $17.25 million, a PE ratio of 2.17 and a beta of -0.41. Advanced Biomed has a 52-week low of $3.61 and a 52-week high of $24.23. The business’s 50 day moving average price is $7.87 and its two-hundred day moving average price is $5.89.

Analyst Ratings Changes

ADVB has been the topic of a number of recent analyst reports. Weiss Ratings upgraded Advanced Biomed from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Thursday, July 23rd. Wall Street Zen upgraded shares of Advanced Biomed to a “hold” rating in a research note on Saturday, August 22nd. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

Advanced Biomed Company Profile

Our Mission We are committed to the application research of integrating semiconductor technology and biotechnology. Through the enrichment, capture, and identification of circulating tumor cells and related tumor marker cells in the field of liquid biopsy, we aim to provide cancer patients with rapid and affordable assay products and services. These services include early screening and detection, diagnosis and staging, treatment selection, and patient outcome interventions for cancer. We are a holding company incorporated in the State of Nevada.